Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes
Launched by NICKOLAS GARBIS · Dec 9, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical technique called conjoint tendon lengthening, which may help prevent or reduce shoulder pain after a procedure known as reverse shoulder arthroplasty (a type of shoulder replacement surgery). Some patients experience pain at the front of their shoulder after this surgery, possibly due to changes in how the shoulder joint aligns. By cutting and lengthening the conjoint tendon, the hope is to relieve the tension and pressure that can cause this pain.
To participate in this trial, you need to be at least 18 years old and scheduled for your first reverse shoulder replacement surgery at one of the participating hospitals in Illinois. Unfortunately, if you are pregnant, have had certain prior surgeries on your shoulder, or are under 18, you won't be eligible. If you join the trial, you will receive the standard care for your surgery, along with the potential benefits of the tendon lengthening procedure. The study aims to see if this technique makes a difference in reducing shoulder pain one year after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are at least 18 years old undergoing primary reverse total shoulder arthroplasty
- • Operations that occur at Loyola University Medical Center (Maywood, IL), Loyola Ambulatory Surgery Center (Maywood, IL), or Gottlieb Memorial Hospital
- Exclusion Criteria:
- • Patients younger than 18 years old
- • Patients who had prior coracoid transfer procedure
- • Patients who are undergoing revision surgery from a prior arthroplasty
- • Current pregnancy As per standard protocol with all surgeries, a urine pregnancy test is performed prior to surgery. If positive, the surgery will be cancelled and the patient will be excluded from the research study.
About Nickolas Garbis
Nickolas Garbis is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in managing and overseeing clinical studies, he focuses on innovative therapies and cutting-edge treatments across various therapeutic areas. Nickolas is recognized for his strategic approach to trial design, regulatory compliance, and patient recruitment, ensuring that studies are conducted efficiently and ethically. His passion for enhancing healthcare drives his collaborative efforts with researchers, institutions, and stakeholders, fostering an environment of innovation and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maywood, Illinois, United States
Patients applied
Trial Officials
Nickolas G Garbis, MD
Principal Investigator
Loyola University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported